136 related articles for article (PubMed ID: 2295859)
1. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
Norden CW; Budinsky A
J Infect Dis; 1990 Jan; 161(1):52-3. PubMed ID: 2295859
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
Norden CW; Shinners E; Niederriter K
J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
[TBL] [Abstract][Full Text] [Related]
4. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
[TBL] [Abstract][Full Text] [Related]
6. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
Norden CW; Shaffer M
J Infect Dis; 1983 Feb; 147(2):352-7. PubMed ID: 6827150
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
[TBL] [Abstract][Full Text] [Related]
10. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Fasching CE; Peterson LR; Moody JA; Sinn LM; Gerding DN
J Lab Clin Med; 1990 Nov; 116(5):697-706. PubMed ID: 1967132
[TBL] [Abstract][Full Text] [Related]
11. Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.
Norden CW
Rev Infect Dis; 1983; 5 Suppl 3():S491-4. PubMed ID: 6635438
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.
Norden CW; Keleti E
Antimicrob Agents Chemother; 1980 Apr; 17(4):591-4. PubMed ID: 7396451
[TBL] [Abstract][Full Text] [Related]
13. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.
Norden CW; Niederreiter K; Shinners EM
Infection; 1986; 14(3):136-8. PubMed ID: 2942488
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ampicillin/sulbactam combination in experimental shunt infections caused by Staphylococcus epidermidis. A light and scanning electron microscope study.
Gedikoğlu Y; Colak A; Benli K; Erbengi T
J Neurosurg Sci; 1993 Mar; 37(1):19-23. PubMed ID: 8366363
[TBL] [Abstract][Full Text] [Related]
15. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis.
Gürsel I; Korkusuz F; Türesin F; Alaeddinoglu NG; Hasirci V
Biomaterials; 2001 Jan; 22(1):73-80. PubMed ID: 11085386
[TBL] [Abstract][Full Text] [Related]
16. Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.
Norden CW
J Infect Dis; 1978 Feb; 137(2):155-60. PubMed ID: 627735
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis.
Jacob E; Setterstrom JA; Bach DE; Heath JR; McNiesh LM; Cierny G
Clin Orthop Relat Res; 1991 Jun; (267):237-44. PubMed ID: 2044286
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
[TBL] [Abstract][Full Text] [Related]
19. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
O'Reilly T; Kunz S; Sande E; Zak O; Sande MA; Täuber MG
Antimicrob Agents Chemother; 1992 Dec; 36(12):2693-7. PubMed ID: 1336342
[TBL] [Abstract][Full Text] [Related]
20. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits.
Shirtliff ME; Mader JT; Calhoun J
Clin Orthop Relat Res; 1999 Feb; (359):229-36. PubMed ID: 10078148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
